ExodusPoint Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-22,794
| Closed | -$9.18M | – | 1916 |
|
2024
Q4 | $9.18M | Buy |
+22,794
| New | +$9.18M | 0.06% | 260 |
|
2024
Q2 | – | Sell |
-52,300
| Closed | -$21.9M | – | 1873 |
|
2024
Q1 | $21.9M | Buy |
+52,300
| New | +$21.9M | 0.17% | 72 |
|
2023
Q2 | – | Sell |
-64,541
| Closed | -$20.3M | – | 2171 |
|
2023
Q1 | $20.3M | Buy |
64,541
+34,073
| +112% | +$10.7M | 0.17% | 86 |
|
2022
Q4 | $8.8M | Buy |
+30,468
| New | +$8.8M | 0.13% | 191 |
|
2022
Q3 | – | Sell |
-3,751
| Closed | -$1.06M | – | 2275 |
|
2022
Q2 | $1.06M | Buy |
+3,751
| New | +$1.06M | 0.01% | 1009 |
|
2022
Q1 | – | Sell |
-44,933
| Closed | -$9.87M | – | 2643 |
|
2021
Q4 | $9.87M | Buy |
44,933
+5,821
| +15% | +$1.28M | 0.1% | 207 |
|
2021
Q3 | $7.1M | Buy |
39,112
+13,450
| +52% | +$2.44M | 0.1% | 261 |
|
2021
Q2 | $5.17M | Buy |
25,662
+16,065
| +167% | +$3.24M | 0.06% | 302 |
|
2021
Q1 | $2.06M | Sell |
9,597
-9,316
| -49% | -$2M | 0.03% | 531 |
|
2020
Q4 | $4.47M | Buy |
18,913
+12,091
| +177% | +$2.86M | 0.04% | 259 |
|
2020
Q3 | $1.86M | Sell |
6,822
-7,786
| -53% | -$2.12M | 0.04% | 392 |
|
2020
Q2 | $4.24M | Buy |
14,608
+12,370
| +553% | +$3.59M | 0.11% | 177 |
|
2020
Q1 | $533K | Buy |
+2,238
| New | +$533K | 0.03% | 421 |
|
2019
Q4 | – | Sell |
-8,776
| Closed | -$1.49M | – | 1857 |
|
2019
Q3 | $1.49M | Buy |
8,776
+1,956
| +29% | +$331K | 0.05% | 271 |
|
2019
Q2 | $1.25M | Buy |
+6,820
| New | +$1.25M | 0.05% | 199 |
|